212 related articles for article (PubMed ID: 22510351)
1. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
Leng S; Do K; Yingling CM; Picchi MA; Wolf HJ; Kennedy TC; Feser WJ; Baron AE; Franklin WA; Brock MV; Herman JG; Baylin SB; Byers T; Stidley CA; Belinsky SA
Clin Cancer Res; 2012 Jun; 18(12):3387-95. PubMed ID: 22510351
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
3. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
4. Gene promoter methylation in plasma and sputum increases with lung cancer risk.
Belinsky SA; Klinge DM; Dekker JD; Smith MW; Bocklage TJ; Gilliland FD; Crowell RE; Karp DD; Stidley CA; Picchi MA
Clin Cancer Res; 2005 Sep; 11(18):6505-11. PubMed ID: 16166426
[TBL] [Abstract][Full Text] [Related]
5. 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.
Leng S; Liu Y; Weissfeld JL; Thomas CL; Han Y; Picchi MA; Edlund CK; Willink RP; Gaither Davis AL; Do KC; Nukui T; Zhang X; Burki EA; Van Den Berg D; Romkes M; Gauderman WJ; Crowell RE; Tesfaigzi Y; Stidley CA; Amos CI; Siegfried JM; Gilliland FD; Belinsky SA
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713168
[TBL] [Abstract][Full Text] [Related]
6. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
7. Dietary Nutrient Intake, Ethnicity, and Epigenetic Silencing of Lung Cancer Genes Detected in Sputum in New Mexican Smokers.
Leng S; Picchi MA; Kang H; Wu G; Filipczak PT; Juri DE; Zhang X; Gauderman WJ; Gilliland FD; Belinsky SA
Cancer Prev Res (Phila); 2018 Feb; 11(2):93-102. PubMed ID: 29118161
[TBL] [Abstract][Full Text] [Related]
8. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.
Belinsky SA; Leng S; Wu G; Thomas CL; Picchi MA; Lee SJ; Aisner S; Ramalingam S; Khuri FR; Karp DD
Cancer Prev Res (Phila); 2017 Nov; 10(11):635-640. PubMed ID: 28904059
[TBL] [Abstract][Full Text] [Related]
9. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
10. Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion.
Bruse S; Petersen H; Weissfeld J; Picchi M; Willink R; Do K; Siegfried J; Belinsky SA; Tesfaigzi Y
Respir Res; 2014 Jan; 15(1):2. PubMed ID: 24405663
[TBL] [Abstract][Full Text] [Related]
11. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.
Belinsky SA; Grimes MJ; Casas E; Stidley CA; Franklin WA; Bocklage TJ; Johnson DH; Schiller JH
Br J Cancer; 2007 Apr; 96(8):1278-83. PubMed ID: 17406356
[TBL] [Abstract][Full Text] [Related]
12. Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico.
Leng S; Liu Y; Thomas CL; Gauderman WJ; Picchi MA; Bruse SE; Zhang X; Flores KG; Van Den Berg D; Stidley CA; Gilliland FD; Belinsky SA
Am J Respir Crit Care Med; 2013 Nov; 188(9):1110-6. PubMed ID: 24032348
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Belinsky SA; Liechty KC; Gentry FD; Wolf HJ; Rogers J; Vu K; Haney J; Kennedy TC; Hirsch FR; Miller Y; Franklin WA; Herman JG; Baylin SB; Bunn PA; Byers T
Cancer Res; 2006 Mar; 66(6):3338-44. PubMed ID: 16540689
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Methylation Panel in the Promoter Region of
Mohammed F; Baydaa Abed Hussein A; Ahmed T
Arch Razi Inst; 2022 Jun; 77(3):1075-1081. PubMed ID: 36618318
[TBL] [Abstract][Full Text] [Related]
15. Gene Promoter Hypermethylation Detected in Sputum Predicts FEV
Leng S; Diergaarde B; Picchi MA; Wilson DO; Gilliland FD; Yuan JM; Siegfried JM; Belinsky SA
Am J Respir Crit Care Med; 2018 Jul; 198(2):187-196. PubMed ID: 29437466
[TBL] [Abstract][Full Text] [Related]
16. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
17. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
18. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
Leng S; Bernauer AM; Hong C; Do KC; Yingling CM; Flores KG; Tessema M; Tellez CS; Willink RP; Burki EA; Picchi MA; Stidley CA; Prados MD; Costello JF; Gilliland FD; Crowell RE; Belinsky SA
Clin Cancer Res; 2011 Apr; 17(7):2014-23. PubMed ID: 21355081
[TBL] [Abstract][Full Text] [Related]
19. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
20. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.
Varella-Garcia M; Schulte AP; Wolf HJ; Feser WJ; Zeng C; Braudrick S; Yin X; Hirsch FR; Kennedy TC; Keith RL; Barón AE; Belinsky SA; Miller YE; Byers T; Franklin WA
Cancer Prev Res (Phila); 2010 Apr; 3(4):447-53. PubMed ID: 20332298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
